G. Ishioka

发表

Structural Features of Peptide Analogs of Human Histocompatibility Leukocyte Antigen Class I Epitopes That Are More Potent and Immunogenic than Wild-Type Peptide

John Sidney, Alessandro Sette, Scott Southwood, 2001, The Journal of experimental medicine.

Optimizing vaccine design for cellular processing, MHC binding and TCR recognition.

J Alexander, A Sette, J Sidney, 2002, Tissue antigens.

Improved Immunogenicity of an Immunodominant Epitope of the Her-2/neu Protooncogene by Alterations of MHC Contact Residues1

J. Sidney, A. Sette, R. Kiessling, 2004, The Journal of Immunology.

Lipopeptide particles as the immunologically active component of CTL inducing vaccines.

A. Sette, R. Fujinami, R. Chesnut, 1999, Vaccine.

Induction of immune responses and clinical efficacy in a phase II trial of IDM-2101, a 10-epitope cytotoxic T-lymphocyte vaccine, in metastatic non-small-cell lung cancer.

N. Senzer, J. Nemunaitis, M. Morse, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Antigen analogs as therapeutic agents.

H. Grey, A. Sette, S. Hedrick, 1995, Advances in experimental medicine and biology.

Epitope identification and vaccine design for cancer immunotherapy.

J. Sidney, A. Sette, R. Chesnut, 2002, Current opinion in investigational drugs.

Immunization of cancer patients with HER-2/neu-derived peptides demonstrating high-affinity binding to multiple class II alleles.

T. Gooley, K. Knutson, K. Schiffman, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Pre-Clinical Evaluation of a Replication-Competent Recombinant Adenovirus Serotype 4 Vaccine Expressing Influenza H5 Hemagglutinin

J. Avanzini, J. Alexander, M. Newman, 2012, PloS one.

Universal influenza DNA vaccine encoding conserved CD4+ T cell epitopes protects against lethal viral challenge in HLA-DR transgenic mice.

A. Sette, J. Alexander, E. Assarsson, 2010, Vaccine.

Oral Priming with Replicating Adenovirus Serotype 4 Followed by Subunit H5N1 Vaccine Boost Promotes Antibody Affinity Maturation and Expands H5N1 Cross-Clade Neutralization

S. Khurana, J. Manischewitz, L. King, 2015, PloS one.

MHC interaction and T cell recognition of carbohydrates and glycopeptides.

H. Grey, A. Sette, F. Gaeta, 1992, Journal of immunology.

Failure to demonstrate long-lived MHC saturation both in vitro and in vivo. Implications for therapeutic potential of MHC-blocking peptides.

H. Grey, A. Sette, F. Gaeta, 1994, Journal of immunology.

A single TCR antagonist peptide inhibits experimental allergic encephalomyelitis mediated by a diverse T cell repertoire.

A. Sette, V. Kuchroo, R. Sobel, 1994, Journal of immunology.

Formulation and characterization of a ten-peptide single-vial vaccine EP-2101, designed to induce cytotoxic T-lymphocyte responses for cancer immunotherapy

J. Fikes, M. Newman, G. Ishioka, 2008, Human vaccines.

The hepatitis B virus-specific CTL responses induced in humans by lipopeptide vaccination are comparable to those elicited by acute viral infection.

H. Grey, A. Sette, F. Chisari, 1997, Journal of immunology.

Contact Residues Protooncogene by Alterations of MHC Immunodominant Epitope of the Her-2/neu Improved Immunogenicity of an

J. Sidney, A. Sette, R. Kiessling, 2004 .

Dendritic cells generated in vivo by a chimeric hematopoietic growth factor, progenipoietin-4, demonstrate potent immunological function.

A. Sette, R. Chesnut, P. Streeter, 2001, Vaccine.

cDNA cloning and immunological characterization of the rye grass allergen Lol p I.

R. Chesnut, G. Ishioka, M. Pérez, 1990, The Journal of biological chemistry.

Induction of class I MHC-restricted, peptide-specific cytolytic T lymphocytes by peptide priming in vivo.

H. Grey, S. Colon, R. Chesnut, 1989, Journal of immunology.

Recognition of T cell epitopes and lymphokine secretion by rye grass allergen Lolium perenne I-specific human T cell clones.

D. Stevenson, G. Ishioka, L. Beck, 1994, Journal of immunology.

MHC blocking peptides and T-cell receptor antagonists: novel paths to selective immunosuppression?

H. Grey, A. Sette, S. Hedrick, 1995, Chemical immunology.

Major histocompatibility complex class II association and induction of T cell responses by carbohydrates and glycopeptides

H. Grey, A. Sette, F. Gaeta, 1993, Springer Seminars in Immunopathology.

Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study

R. Webby, J. Treanor, P. Wright, 2013, The Lancet. Infectious diseases.

Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans.

A. Vitiello, H. Grey, F. Chisari, 1995, The Journal of clinical investigation.

Pre-Clinical Development of a Recombinant, Replication-Competent Adenovirus Serotype 4 Vector Vaccine Expressing HIV-1 Envelope 1086 Clade C

H. Liao, B. Haynes, D. Montefiori, 2013, PloS one.

Delayed hypersensitivity and immune protection against herpes simplex virus: suppressor T cells that regulate the induction of delayed hypersensitivity effector T cells also regulate the induction of protective T cells.

L. Pizer, G. Ishioka, R. Schrier, 1985, Journal of immunology.

Identification of broad binding class I HLA supertype epitopes to provide universal coverage of influenza A virus.

J. Sidney, A. Sette, M. Kotturi, 2010, Human immunology.

Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes.

G Y Ishioka, J Fikes, G Hermanson, 1999, Journal of immunology.

Design and testing of peptide-based cytotoxic T-cell-mediated immunotherapeutics to treat infectious diseases and cancer.

A. Vitiello, H. Grey, A. Sette, 1995, Pharmaceutical biotechnology.

Definition of a DQ3.1-specific binding motif.

M F del Guercio, C Oseroff, A Sette, 1994, Journal of immunology.

Characterization of an in situ IFN-gamma ELISA assay which is able to detect specific peptide responses from freshly isolated splenocytes induced by DNA minigene immunization.

A Sette, A. Sette, G. Ishioka, 2000, Journal of immunological methods.

DRB1*0301 molecules recognize a structural motif distinct from the one recognized by most DR beta 1 alleles.

J. Sidney, A. Sette, F. Koning, 1992, Journal of immunology.

Antigen analogs/MHC complexes as specific T cell receptor antagonists.

J Alexander, A Sette, H. Grey, 1994, Annual review of immunology.

A Decaepitope Polypeptide Primes for Multiple CD8+ IFN-γ and Th Lymphocyte Responses: Evaluation of Multiepitope Polypeptides as a Mode for Vaccine Delivery1

A. Sette, E. Appella, R. Chesnut, 2002, The Journal of Immunology.

T cell receptor antagonist peptides are highly effective inhibitors of experimental allergic encephalomyelitis

H. Grey, A. Sette, V. Kuchroo, 1994, European journal of immunology.

A Degenerate HLA-DR Epitope Pool of HER-2/neu Reveals a Novel In vivo Immunodominant Epitope, HER-2/neu88-102

Soldano Ferrone, James N Ingle, L. Hartmann, 2010, Clinical Cancer Research.

An HLA-DR-degenerate epitope pool detects insulin-like growth factor binding protein 2-specific immunity in patients with cancer.

L. Hartmann, P. Wettstein, K. Knutson, 2008, Cancer research.

Lipopolysaccharide-specific memory B cell responses to an attenuated live cholera vaccine are associated with protection against Vibrio cholerae infection.

M. Levine, Wilbur H. Chen, M. Sztein, 2018, Vaccine.

Identification of a broad coverage HLA-DR degenerate epitope pool derived from carcinoembryonic antigen

L. Hartmann, A. Nassar, J. Ingle, 2009, Cancer Immunology, Immunotherapy.

Different forms of membrane-associated herpes simplex virus glycoproteins induce functionally distinct subsets of herpes simplex virus-specific suppressor T cells

L. Pizer, G. Ishioka, J. Moorhead, 1985, Journal of virology.

Anticancer Activity of Narcissus Extracts in Mice 1

S. Furusawa, G. Ishioka, E. Furusawa, 1973, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Structural Features of Peptide Analogs of Human Histocompatibility Leukocyte Antigen Class I Epitopes That Are More Potent and Immunogenic than Wild-Type Peptide

J. Sidney, A. Sette, S. Southwood, 2001, The Journal of experimental medicine.

Induction of immune responses and clinical efficacy in a phase II trial of IDM-2101, a 10-epitope cytotoxic T-lymphocyte vaccine, in metastatic non-small-cell lung cancer.

N. Senzer, M. Morse, J. Stephenson, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.